These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 3161758

  • 1. Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome.
    Buvat J, Buvat-Herbaut M, Marcolin G, Racadot A, Fourlinnie JC, Fossati P.
    Fertil Steril; 1985 Sep; 44(3):356-60. PubMed ID: 3161758
    [Abstract] [Full Text] [Related]

  • 2. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease.
    Steingold KA, Lobo RA, Judd HL, Lu JK, Chang RJ.
    J Clin Endocrinol Metab; 1986 May; 62(5):1048-51. PubMed ID: 2937800
    [Abstract] [Full Text] [Related]

  • 3. Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.
    Carmina E, Rosato F, Maggiore M, Gagliano AM, Indovina D, Jannì A.
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):99-104. PubMed ID: 6229966
    [Abstract] [Full Text] [Related]

  • 4. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J, Buvat-Herbaut M, Marcolin G, Racadot A, Fourlinnie JC, Beuscart R, Fossati P.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [Abstract] [Full Text] [Related]

  • 5. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [Abstract] [Full Text] [Related]

  • 6. Bromocriptine treatment in anovulation with decreased ratio of follicle stimulating hormone to luteinizing hormone and with hyperandrogenism.
    Suginami H, Kuroda G, Yano K, Kitagawa H, Matsuura S.
    Endocrinol Jpn; 1988 Feb; 35(1):47-55. PubMed ID: 2969329
    [Abstract] [Full Text] [Related]

  • 7. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A, Rosenn B, Palti Z, Ebstein B, Har-Nir R, Ron M.
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [Abstract] [Full Text] [Related]

  • 8. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F.
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [Abstract] [Full Text] [Related]

  • 10. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S, Kondoh K, Kubo T.
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [Abstract] [Full Text] [Related]

  • 11. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M, L'Hermite M, Hedouin-Quincampoix M, Fossati P.
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [Abstract] [Full Text] [Related]

  • 12. [Comprehensive approach to clinical background and effect of bromocriptine administration in patients with endocrinological polycystic ovarian disease].
    Aisaka K, Kaneda S, Tsuzuki H, Tawada T, Kokuho K, Toriya Y, Nojima M, Yoshida K, Mori H.
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb 20; 66(2):101-12. PubMed ID: 2332079
    [Abstract] [Full Text] [Related]

  • 13. Effect of epimestrol on gonadotropin and prolactin plasma levels and response to luteinizing hormone-releasing hormone/thyrotropin-releasing hormone in secondary amenorrhea and oligomenorrhea.
    Genazzani AR, Facchinetti F, de Leo V, Picciolini E, Franchi F, Parrini D, Kicovic PM.
    Fertil Steril; 1978 Dec 20; 30(6):654-60. PubMed ID: 153243
    [Abstract] [Full Text] [Related]

  • 14. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep 20; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 15. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A.
    J Reprod Med; 1984 Mar 20; 29(3):193-6. PubMed ID: 6233421
    [Abstract] [Full Text] [Related]

  • 16. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W, Solbach HG, Kley HK, Nieschlag E, Rudorff KH, Krüskemper HL.
    Horm Res; 1976 Mar 20; 7(1):1-10. PubMed ID: 793974
    [Abstract] [Full Text] [Related]

  • 17. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
    Huang HJ, Ishimaru T, Yamabe T.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):265-78. PubMed ID: 3136040
    [Abstract] [Full Text] [Related]

  • 18. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1987 Aug 20; 10(4):389-95. PubMed ID: 3119696
    [Abstract] [Full Text] [Related]

  • 19. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia].
    Mori H, Aisaka K, Matsuoka R, Kigawa T.
    Nihon Naibunpi Gakkai Zasshi; 1985 Jan 20; 61(1):48-55. PubMed ID: 3922814
    [Abstract] [Full Text] [Related]

  • 20. Depressed follicle-stimulating hormone, luteinizing hormone, and prolactin responses to the luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide test in endurance runners in the hard-training season.
    Ronkainen H.
    Fertil Steril; 1985 Dec 20; 44(6):755-9. PubMed ID: 3935485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.